LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    Is AstraZeneca plc or GlaxoSmithKline plc the best Black Friday buy?

    Will AstraZeneca plc (LON: AZN) or GlaxoSmithKline plc (LON: GSK) soar over the medium-to-long term?

    Read more »

    Investing Articles

    Are these 2 stocks the income heroes your portfolio needs?

    These two stocks pay income of more than 5% a year. Harvey Jones examines whether this rate of return is…

    Read more »

    Investing Articles

    Should you dump AstraZeneca plc and buy BTG plc after 10% sales rise?

    Does BTG plc (LON: BTG) offer superior growth potential to AstraZeneca plc (LON: AZN)?

    Read more »

    Investing Articles

    Clinigen Group plc vs AstraZeneca plc: which is the hotter healthcare stock?

    Royston Wild considers the investment potential of medicine mammoths Clinigen Group plc (LON: CLIN) and AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    Why AstraZeneca plc may still not be cheap enough to beat this upstart

    Roland Head takes a look at the latest figures from AstraZeneca plc (LON:AZN) and considers a potential alternative.

    Read more »

    Investing Articles

    Should you invest in pills or joints?

    Which of these stocks should be on your shopping list today?

    Read more »

    Investing Articles

    2 firms to hold until you retire and beyond

    Brexit looks like a sideshow for these enduring businesses.

    Read more »

    Investing Articles

    These FTSE 100 stocks sank in October. Time to stock up?

    Royston Wild runs the rule over two recent FTSE 100 (INDEXFTSE: UKX) losers.

    Read more »

    Investing Articles

    The Good, the Bad and the Ugly of pharma stocks

    Bilaal Mohamed reveals his best and worst picks from the pharmaceuticals sector.

    Read more »

    Investing Articles

    Can these 2 stocks deliver healthy dividends forever?

    A dividend stock isn't just for today, it should deliver the goods year after year after year, says Harvey Jones.

    Read more »

    Investing Articles

    Should you buy this stock after it reports a 27% rise in revenue?

    Is this company set to soar after positive results?

    Read more »

    Investing Articles

    Forget short-term pain! Buy these FTSE 100 stars for long-term gain

    Royston Wild looks at two brilliant FTSE 100 (INDEXFTSE: UKX) stocks for long-term investors.

    Read more »